INMB
INmune Bio (INMB)
$40
About INmune Bio (INMB)
INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.
Details
Daily high
$4.60
Daily low
$4.32
Price at open
$4.36
52 Week High
$14.74
52 Week Low
$4.32
Market cap
97.6M
Dividend yield
0.00%
Volume
402,171
Avg. volume
220,080
P/E ratio
-2.01
INmune Bio News
Details
Daily high
$4.60
Daily low
$4.32
Price at open
$4.36
52 Week High
$14.74
52 Week Low
$4.32
Market cap
97.6M
Dividend yield
0.00%
Volume
402,171
Avg. volume
220,080
P/E ratio
-2.01